- Report
- May 2022
- 134 Pages
Global
From €3456EUR$3,500USD£2,886GBP
- Report
- May 2022
- 53 Pages
Global
From €2469EUR$2,500USD£2,061GBP
- Report
- May 2022
- 89 Pages
Global
From €2469EUR$2,500USD£2,061GBP
- Report
- May 2022
- 72 Pages
Global
From €2469EUR$2,500USD£2,061GBP
- Report
- May 2022
- 77 Pages
Global
From €2469EUR$2,500USD£2,061GBP
- Report
- May 2022
- 48 Pages
Global
From €2469EUR$2,500USD£2,061GBP
- Report
- April 2022
- 632 Pages
Global
From €2469EUR$2,500USD£2,061GBP
- Report
- April 2022
- 48 Pages
Global
From €1975EUR$2,000USD£1,649GBP
- Report
- April 2022
- 28 Pages
Global
From €1975EUR$2,000USD£1,649GBP
- Drug Pipelines
- June 2021
- 847 Pages
Global
From €2469EUR$2,500USD£2,061GBP
- Drug Pipelines
- March 2021
Global
From €2469EUR$2,500USD£2,061GBP
- Drug Pipelines
- August 2020
- 35 Pages
Global
From €1975EUR$2,000USD£1,649GBP
- Report
- July 2022
- 40 Pages
Argentina
From €1481EUR$1,500USD£1,237GBP
- Report
- July 2022
- 40 Pages
Poland
From €1481EUR$1,500USD£1,237GBP
From €1481EUR$1,500USD£1,237GBP
- Report
- July 2022
- 40 Pages
United Kingdom
From €1481EUR$1,500USD£1,237GBP
- Report
- July 2022
- 40 Pages
Vietnam
From €1481EUR$1,500USD£1,237GBP
- Report
- July 2022
- 40 Pages
United States
From €1481EUR$1,500USD£1,237GBP
- Report
- July 2022
- 40 Pages
South Korea
From €1481EUR$1,500USD£1,237GBP
- Report
- July 2022
- 40 Pages
Russia
From €1481EUR$1,500USD£1,237GBP
The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection.
The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more